Whole-cell and single-channel recording techniques were used to study the action of the anticonvulsant drug MK-801 {( + )-5-methyl-10,11-dihydro-5H-dibenzo [a, 
L-Glutamate is thought to serve as the major excitatory neurotransmitter in the central nervous system (1, 2) . Most central neurons express two distinct receptors for excitatory amino acids. The N-methyl-D-aspartate (N-Me-D-Asp) receptor (1-3) is selectively activated by N-Me-D-Asp, whereas kainate and quisqualate serve as selective agonists of non-N-Me-D-Asp receptors (1) (2) (3) . Both receptors activate ion channels that increase the membrane permeability to monovalent cations (4) (5) (6) . In addition, the channel controlled by N-Me-D-Asp receptors conducts Ca2+ (6) (7) (8) .
Electrophysiological responses to N-Me-D-Asp are blocked by competitive antagonists of the N-Me-D-Asp receptor (9) and by a number of divalent cations, including Mg2+ (6, (10) (11) (12) . A third group of compounds that antagonize responses to N-Me-D-Asp, but that do not compete for the N-Me-D-Asp binding site, include the dissociative anesthetics ketamine and phencyclidine (13) (14) (15) (16) (17) and the o, opioid SKF 10,047 (17, 18) . Recently, Wong and colleagues (19, 20) have shown that the anticonvulsant compound MK-801 {( + )-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate} belongs to this third class of antagonists. MK-801 competes with the binding of SKF 10,047, ketamine, and phencyclidine to rat cortical membranes and it antagonizes the depolarization of cortical tissue by bathapplied N-Me-D-Asp (19) .
We have investigated the action of MK-801 on currents elicited by excitatory amino acids in rat cortical neurons maintained in dissociated tissue culture. When applied simultaneously with N-Me-D-Asp, MK-801 produced a longlasting blockade of the current evoked by N-Me-D-Asp but did not affect responses to kainate and quisqualate. The properties of blockade by MK-801 suggest that the drug cannot bind or unbind unless the channel has been opened by transmitter and that the drug probably binds within the channel pathway itself.
METHODS
Neurons were dissociated from the visual cortex of 2-to 6-day-old Long Evans rat pups and grown in culture for days as described (21) . Currents activated by excit-fory amino acids were measured in the whole-cell and outside-out patch-clamp configurations (22) . Pipettes contained an internal solution (in mM) of 120 cesium methanesulfonate, 5 CsCI, 10 Cs2EGTA, 5 Mg(OH)2, 5 MgATP, 1 Na2GTP, and 10 Hepes (pH adjusted to 7.4 with CsOH). The external solution (in mM) was 160 NaCl, 2 CaC12, and 10 Hepes (pH 7.40). In whole-cell experiments, 300 nM tetrodotoxin and 10 kLM bicuculline methiodide were added to the external solution to suppress spontaneous activity. MK-801, the kind gift of Paul Anderson (Merck Sharp & Dohme), was added from stock solutions of 2-50 mM in ethanol, stored at -20'C. Final concentrations of ethanol were <0.1%. Cells or patches were bathed in control or agonist-containing external solution flowing from one of a linear array of 7-10 microcapillary tubes fed by gravity (23) . Rapid solution changes were made by moving the array of tubes relative to the cell (whole-cell) or by moving the pipette relative to the tubes (patch). All experiments were done at 20-250C. tory amino acids, quisqualate and kainate, elicited inward currents that were unchanged even during a period when MK-801 had blocked the response to N-Me-D-Asp by >90%o. In addition, when MK-801 was applied simultaneously with either quisqualate or kainate it did not reduce the response to these compounds and it did not cause a reduction in the response to a subsequent application of N-Me-D-Asp alone.
Recovery from MK-801 blockade was very slow in the absence of N-Me-D-Asp. In six cells, brief pulses of N-Me-D-Asp were applied every 5-10 min to test for recovery from MK-801 blockade (e.g., Fig. 3A ). After 20-30 min of perfusion with control solution, the current induced by N-Me-DAsp recovered to only about 10% of the initial response. Recovery was much faster when N-Me-D-Asp was applied continuously to the cell; in this case, substantial recovery could be seen over 4-5 min in some cells (Fig. 3B) , with a mean r (in seven cells) of about 90 min at -70 mV. A dramatic acceleration of recovery from blockade was observed when cells were held at + 30 mV during the application of N-Me-D-Asp; in this case (where current flow was outward), nearly complete recovery was seen in 4-5 min (Fig. 3C ). Holding at + 30 mV in the absence of N-Me-D-Asp did not enhance the rate of recovery from MK-801. Table 1 shows the X values of onset of blockade by MK-801 and of recovery from blockade by MK-801 at + 30 mV and -70 mV (the fits with single exponentials were usually good but not perfect). Despite the pronounced voltage dependence of recovery, the rate of development of block was no different at + 30 mV than at -70 mV. Table 1 Table 1 ). MK-801 was effective, however, only when applied simultaneously with N-Me-D-Asp (Fig. 1C) . Application of MK-801 alone had no effect on the holding current and had little effect on the response of the cell to a subsequent application of N-Me-D-Asp. This result suggests that the MK-801 can exert its blocking action only when the receptor has been activated by agonist.
As shown in Fig. 2 with concentrations as low as 10 nM, but the development of block was too slow to quantitate.
Effect of Mg2". In agreement with previous work (6, 8, 11) , physiological levels of Mg2+ caused a substantial reduction in the current activated by N-Me-D-Asp at holding potentials of -70 to -80 mV (Fig. 4A) , but MK-801 still produced a long-lasting blockade of the N-Me-D-Aspinduced current in 0.5-1 mM Mg2 . In solutions containing 10 mM Mg2 + (Fig. 4B) (Fig. 3) . (iii) MK-801 most likely binds within the channel pathway itself. This conclusion comes from the ability of Mg2+, which produces ionic blockade of the channel (6, 8, 11) , to prevent MK-801 block from occurring (Fig. 4) . M -1'sec -1) obtained by Neher and Steinbach (27) (28, 29) , will be relatively unaffected by MK-801, whereas more complicated synaptic events involving N-Me-D-Asp receptors-including long-term potentiation (29) and epileptic activity-would be susceptible to block. Because of the slow onset and a long duration of blockade by MK-801, the drug's effect will accumulate in a use-dependent way with repeated channel activation (cf. refs. 14 and 19); the depth of block will depend in a complicated way on the rate and pattern of synaptic activation. N-Me-D-Asp receptors have been implicated in neuronal damage due to anoxia and hyperexcitation (30) (31) (32) (33) ; the properties of blockade by MK-801 may underlie its potential clinical value for treatment of stroke and epilepsy while minimizing disruption of normal brain function.
